Martha J. Demski

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Damon A. Terrill For: Martha Demski
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Martha J. Demski

Form 4 holding Director

ADMA BIOLOGICS, INC.

Security class
Common Stock
Shares / value
56,601
Estimated value
$255,837
Report date
06 Mar 2023
Price
$4.52
Ownership
Indirect
Form 4 holding Director

ADMA BIOLOGICS, INC.

Security class
Employee Stock Option (right to buy)
Shares / value
51,630
Estimated value
$188,966
Report date
06 Mar 2023
Price
$3.66
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CHIMERIX INC

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
21 Apr 2025
Price
$8.55
Ownership
By the Martha J. Demski Trust u/a 10/01/94
Form 4 holding Director

Equillium, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
70,000
Estimated value
Report date
28 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Alpha Teknova, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
55,000
Estimated value
Report date
01 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Equillium, Inc.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
22 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Adamas Pharmaceuticals Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
$5.16
Ownership
Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee
Form 4 holding Director

Adamas Pharmaceuticals Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CHIMERIX INC

Security class
Employee Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
21 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Martha J. Demski

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .